Pseudomonas cepacia produces at least two extracellular proteases with apparent molecular masses of 36,000 and 40,000 Da. The 36-kDa protease has high proteolytic activity and the 40-kDa protease has low proteolytic activity with hide powder azure as a substrate. Monoclonal antibodies (MAbs) were raised against the purified 36-and 40-kDa proteases. Several MAbs directed against the 36-kDa protease were found to recognize the 40-kDa protease by Western immunoblot analysis. Similarly, a MAb directed against the 40-kDa protease recognized the 36-kDa protease, suggesting that these two proteases may be immunologically related. A MAb directed against the 36-kDa protease, designated 36-6-8, and a MAb directed against the 40-kDa protease (MAb G-11) cross-reacted with other extracellular proteases, such as Pseudomonas aeruginosa elastase and alkaline protease, Pseudomonas pseudomaUlei protease, and the Vibrio chokrae hemagglutinin/protease. MAb 36-6-8 neutralized the P. cepacia 36-kDa protease, P. aeruginosa elastase, P. pseudomaUei protease, and V. cholerae hemagglutinin/protease but did not affect P. aeruginosa alkaline protease activity. In contrast, MAb G-11 to the 40-kDa protease neutralized only the P. cepacia 36-kDa protease. This evidence suggests that the neutralizing MAb, 36-6-8, recognizes an epitope conserved among some metalloproteases. This epitope may lie at or near the active site of the P. cepacia 36-kDa protease and P. aeruginosa elastase.
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Staphylococcus aureus, Haemophilus influenzae, and Pseudomonas aeruginosa are the bacterial pathogens largely responsible for pulmonary exacerbations in cystic fibrosis (CF) patients. However, more recently, Pseudomonas cepacia has been reported to cause pulmonary infections in children and young adults with CF late in the course of the disease (11, 28, 32) . Colonization with P. cepacia is associated with poor prognosis and in some patients may lead to severe necrotizing pneumonia and death (11, 27, 28, 29) . Clinical factors which may predispose CF patients to the acquisition of P. cepacia are increasing age and the severity of the underlying lung disease (28) . The high incidence of P. cepacia colonization in patients at some CF centers (21, 23, 29) , the high risk of colonization associated with hospital admission (29, 32) or with colonization of a sibling (28, 31, 32) , and ribotyping analysis (14, 30) suggest person-to-person and nosocomial transmission ofP. cepacia. P. cepacia tends to be very resistant to antibiotics and disinfectants, and pulmonary infections are very difficult to treat and prevent. Since it may not be appropriate or possible to isolate patients colonized with P. cepacia from noncolonized CF patients, other methods for the treatment and/or prevention of P. cepacia infection may have to be developed.
The pathogenic mechanisms of P. cepacia have not been fully characterized. However, it is known that CF isolates can produce potential virulence factors, such as protease, lipase (16) , and hemolysin (7, 18) . Protease activity was detected in 88% of the isolates examined (16) . The protease was subsequently purified by McKevitt et al. (15) and was found to be a metalloprotease with an apparent molecular mass of 34 kDa. This protease (PSCP) was found to cause bronchopneumonia in rat lungs when instilled intratracheally.
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A number of pathogenic bacteria secrete proteases which may be involved in virulence. P. aeruginosa secretes at least two proteases, elastase and alkaline protease. Elastase is a zincdependent metalloprotease that has been shown to degrade or inactivate a number of biologically important substances, such as fibrin, collagen, complement, and human immunoglobulin G (IgG) (36) . Extensive evidence suggests that elastase is required for maximal virulence of P. aeruginosa (1, 19) . Alkaline protease also appears to be a metalloprotease, since it is inhibited by O-phenanthroline (17) . The three-dimensional structure of alkaline protease was recently elucidated (3). Pseudomonas pseudomallei produces an iron-requiring metalloprotease with a molecular mass of 36 kDa. Antibodies to P. aeruginosa alkaline protease have been shown to cross-react with P. pseudomallei protease (22) . Vibrio cholerae secretes a 33-kDa zinc-metalloprotease (4) which can cleave biologically important substrates such as mucin, fibronectin, and bactoferritin (6). Hase and Finkelstein (8, 9) have demonstrated that the V cholerae hemagglutinin (HA)/protease is related to P. aeruginosa elastase.
In this study, monoclonal antibodies (MAbs) were raised against two proteases purified from culture supernatants of P. cepacia. The cross-reactivity and neutralization capabilities of these MAbs were examined to determine the antigenic similarity between P. cepacia proteases and other metalloproteases.
MATERIALS AND METHODS
Bacterial strains and culture conditions. P. cepacia 715j, isolated from a sputum sample from a CF patient at the Rainbow Babies and Children's Hospital, Cleveland, Ohio, was used as the source of protease. Two milliliters of a culture grown overnight (24 h at 32°C) of P. cepacia 715j was used to inoculate four 2-liter baffled flasks, with each flask containing 500 ml of peptone (5%)-tryptone soy broth (0.25%) (PTSB; Difco). All cultures were incubated for 24 h at 32°C on a Gyrotory shaker (New Brunswick Scientific Co., Edison, N.J.) at 200 cycles per min. All glassware was acid washed and rinsed with deionized H20. All reagents were made with H20 purified by the Milli-Q System (Millipore Corp., Bedford, Mass.).
Proteases. Elastase and alkaline protease, prepared from P. aeruginosa, were purchased from Nagase Biochemical Inc. (Osaka, Japan). V cholerae HA/protease (8) (ELISA) and/or immunoblotting, were transferred to hypoxanthinethymidine (HT) medium and cloned three times by limiting dilutions in 96-well plates (Nunc). Antibody-producing cells (2 x 106) were injected into pristane-primed BALB/c mice for ascitic fluid production.
The isotypes of the antibodies in the ascitic fluid were determined with a mouse typer subisotyping kit (Bio-Rad Laboratories) as recommended by the manufacturer.
MAb was purified from either serum-free tissue culture supernatant or ascitic fluid. Hybridoma cells were grown in HT medium without serum for 2 days. Saturated ammonium sulfate (4°C) was added slowly with stirring to the tissue culture supernatant until a final concentration of 50% NH4SO4 was reached. After incubation on ice for 1 h, the solution was centrifuged at 5,000 x g for 10 min. The pellet was resuspended in a small volume of 20 mM Tris-40 mM NaCl (pH 7.8) and dialyzed overnight at 4°C against 50 to 100 volumes of 20 mM Tris-HCl (pH 7.8)-20 mM NaCl. The sample was then centrifuged for 10 min at 15,000 x g to remove precipitated denatured proteins. The supernatant containing the MAb was used in neutralization assays. MAb was purified from ascitic fluid by hydroxylapatite (HAP) chromatography essentially as described by Stanker et al. (26) . Briefly, ascitic fluid was applied to an HAP column. After a 2 to 3 volume of 0.01 M Na-phosphate wash, bound proteins were eluted with a 0.01 to 0.5 M linear phosphate gradient. Fractions were analyzed for MAb activity by immunoblotting and for purity by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). MAbs were further purified by Sephadex G100 gel filtration chromatography.
ELISA. ELISA was performed essentially as described previously (24, 25) . P. cepacia 715j 36- purified from PTSB culture supernatants as previously described (15) . Ammonium sulfate-precipitated culture supernatants were subjected to DEAE-Sephacel anion-exchange chromatography. As previously found, the majority of the proteolytic activity was found in the Tris-HCl wash from the DEAE-Sephacel column. This proteolytic activity corresponded with a protein with an apparent molecular mass of 36 kDa, as measured by SDS-PAGE, which was further purified by Sephadex G100 gel filtration chromatography (Fig. 1) . The molecular weight of this protease was previously estimated to be 34,000 by McKevitt et al. (15) using gel filtration chromatography. This protease was given the designation PSCP. Eluting the DEAE-Sephacel column with a 0 to 1 M NaCl gradient yielded two peaks with proteolytic activity (Fig. 2) .
The first minor peak was not associated with protein detectable by A280 or Coomassie blue staining. The second peak, containing the majority of the proteolytic activity was associated with a protein with an apparent molecular mass of 40 kDa (Fig. 1) . The specific activities of the 36-and 40-kDa proteins were compared by using hide powder azure as a substrate. The 36-kDa protease had an average specific activity of 36,100 U/mg of protein, whereas the 40-kDa protease had a specific activity of 6.8 U/mg of protein. Thus, the 36-kDa protein was 5,000-fold more proteolytically active than the 40-kDa protein with hide powder azure as a substrate.
MAb production. MAbs were raised against the 36-and 40-kDa proteases as described in Materials and Methods. Five MAbs to the 36-kDa protease (35-1-5, 36-6-6, 36-6-8, 36-5-15, and 36-9-19) and one MAb to the 40-kDa protease (G-11) were analyzed. All the MAbs raised against the 36-kDa protease cross-reacted with the 40-kDa protease. A representative immunoblot is shown in Fig. 3, lanes 1 to 3. Similarly, the MAb to the 40-kDa protease, G-11, recognized the 36-kDa protease (Fig. 3, lanes 4 to 6) . The MAbs to the 36-kDa protease were specific for the 36-and 40-kDa proteins (Fig. 4) , but MAb G-11 recognized smaller proteins which may be degradation products of the 36-and 40-kDa proteases (Fig. 3,  lanes 5 and 6) . The smaller proteins, although readily detected by immunoblotting, are barely visible by Coomassie blue staining. These data suggest that these two proteases have antigenically related epitopes but that MAb G-1 1 recognizes a different antigenic site than MAb 36-6-8 does, since the smaller proteins are not recognized by MAb 36-6-8. All these MAbs were found to be of the IgM isotype.
Immunologic cross-reactivity with other proteases. Previously, polyclonal anti-PSCP was shown to react with P. aeruginosa elastase (15) . Thus, MAb 36-6-8 was examined for cross-reactivity with elastase, alkaline protease, and V cholerae HA/protease. MAb 36-6-8 not only reacted with the P. cepacia 715j 36-and 40-kDa proteases (Fig. 3 ) but also recognized P. aeruginosa elastase and alkaline protease and the V cholerae HA/protease which migrated as a 32-and 33-kDa doublet (Fig.  5) . Similarly, MAb G-11 also reacted with these proteases (Fig.  5 ). In addition, MAb (Table 2) . MAb 36-6-8 had no effect on alkaline protease activity but, surprisingly, lowered trypsin and chymotrypsin activity. MAb G-11 appeared to neutralize only the 36-kDa protease and not the other proteases tested. Interestingly, incubation of MAb 36-6-8 or G-11 with alkaline protease resulted in enhanced proteolytic activity which may be due to activation of a zymogen in ascitic fluid by alkaline protease. Neutralization of the 40-kDa pro- tease could not be tested accurately because of its low specific activity.
Since MAb 36-6-8 (in ascitic fluid) appeared to lower trypsin and chymotrypsin activity, it was deemed possible that other components in the ascitic fluid (e.g., a-2-macroglobulin, albumin) may be manifesting the neutralizing effect. In fact, some commercial preparations of control ascitic fluid were observed to reduce proteolytic activity by as much as 40% (data not shown). Thus, MAb 36-6-8 was semipurified by HAP column chromatography (26) and G100 gel filtration. MAb 36-6-8 was concentrated from the tissue culture supernatant of hybridoma cells grown in the absence of serum for 2 days. Both HAP column-purified MAb 36-6-8 and tissue culture 36-6-8 were found to neutralize elastase, the 36-kDa protease, and V cholerae HA/protease (Table 3) . However, alkaline protease and chymotrypsin (Table 3) were not neutralized. A MAb (MCA-83) to the P. aeruginosa ferripyochelin-binding protein (25) was used in some experiments as a control and this antibody had no effect on the activity of any of the proteases examined (data not shown). Thus, it appears that MAb 36-6-8 can specifically inhibit the activity of the 36-kDa protease, P. aeruginosa elastase, and HAlprotease but has no effect on P. aeruginosa alkaline protease. Partial inhibition of chymotrypsin and trypsin activity with ascitic fluid containing MAb 36-6-8 was probably caused by other components of the ascitic fluid. DISCUSSION Extracellular zinc metalloproteases have been shown to contribute to the bacterial pathogenesis of Legionnaire's disease (2, 35) , P. aeruginosa infection (36, 37) , cholera (5) , and other diseases. P. cepacia also secretes a zinc metalloprotease lanes 1 to 3) or G-11 (lanes 5 to 7). Lanes 1 and 5, P. aeruginosa alkaline protease; lanes 2 and 6, P. aeruginosa elastase; lanes 3 and 7, V cholerae HA/protease; lane 4, molecular mass markers as described in the legend to Fig. 1. (15, 16) which appears to act as a virulence factor (16) . It was demonstrated that intratracheal instillation of purified PSCP into rat lungs produced bronchopneumonia. Although McKevitt et al. (15) identified one extracellular protease, we found that P. cepacia secreted at least two proteases. A 36-kDa protease (PSCP) with high proteolytic activity and a 40-kDa protease with low proteolytic activity were produced. McKevitt et al. (15) may not have detected the 40-kDa protease in the DEAE-Sephacel NaCl gradient because of its low specific activity.
Cross-reactivity of MAbs to PSCP and the 40-kDa protease indicates that these two proteases are immunologically related. It is possible that the 40-kDa protein is a precursor form of PSCP. All extracellular bacterial proteases studied thus far are synthesized in a proenzyme form that is processed to a mature form (for a review, see reference 34). Although processing of these proenzymes generally occurs intracellularly, it has been demonstrated that prolysostaphins of Staphylococcus spp. are converted extracellularly to their mature form, lysostaphin, a zinc-dependent endopeptidase (10) . This extracellular activation may provide protection for the bacteria. In addition, P. aeruginosa alkaline protease is secreted as a zymogen where cleavage of nine N-terminal amino acids yields a mature protein with 470 residues (3). However, it is also possible that the 40-kDa protease is not a precursor of PSCP and that these proteases merely share common antigenic determinants. Currently, the PSCP gene is being cloned in our laboratory. Analysis of the PSCP gene will enable us to determine the exact relationship of these two proteases.
MAb 36-6-8 not only recognized PSCP and the 40-kDa protease but reacted with P. aeruginosa elastase, alkaline protease, a P. pseudomallei protease, and V. cholerae HA/ protease. The finding that these proteins may all be immunologically related is not surprising. Hase and Finkelstein (8) demonstrated that P. aeruginosa elastase and the V. cholerae HA/protease were related structurally, functionally, and immunologically. Polyclonal antisera to elastase and HA/protease were shown to neutralize the proteolytic and elastolytic activities of the reciprocal protease (8) . Moreover, the mature HA/protease has 61.5% amino acid homology with P. aeruginosa elastase (9 Table 2 , except the protease but with no control ascitic fluid was subtracted in each case. Control used as a blank contained only Tris buffer and hide powder azure as a substrate. Each value represents the mean ± standard deviation of three determinations. The asterisks indicate that the values were significantly different from the value for the control by the t test for paired observations (P < 0.01).
b Fractions 64 to 94 from the HAP column were pooled, dialyzed, and concentrated by Amicon filtration.
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